ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CStone registers for Phase I trial of CDK4/6 inhibitor CS3002 in Australia
August 25, 2019An open-label, multi-dose, dose-escalation, and dose-expansion Phase I clinical study designed to evaluate the safety, tolerability, pharmacokinetics, and anti-tumour efficacy of CS3002 in patients with advanced solid tumours -
First Volunteers Dosed in Phase I Clinical Trial of PBT434
July 11, 2018Prana Biotechnology has announced the first cohort of volunteers in its Phase I clinical trial have been administered PBT434, an experimental drug under investigation for the treatment of Parkinsonian diseases.
Pharma Sources Insight January 2025
